Hacker News
- Phase3 Trial:Remdesivir Significantly Reduced Risk of Hospitalization with Covid https://www.gilead.com/news-and-press/press-room/press-releases/2021/9/veklury-remdesivir-significantly-reduced-risk-of-hospitalization-in-highrisk-patients-with-covid19 13 comments
- Data on 53 Patients Treated With Investigational Antiviral Remdesivir https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/data-on-53-patients-treated-with-investigational-antiviral-remdesivir-through-the-compassionate-use-program-published-in-new-england-journal-of-medici 30 comments
- Expanded access programs for Remdesivir https://www.gilead.com/stories/articles/an-update-on-covid-19-from-our-chairman-and-ceo 71 comments
- Gilead’s update on response to COVID-19 using Remdesivir https://www.gilead.com/purpose/advancing-global-health/covid-19 6 comments
- Gilead Sciences Requests to Rescind Remdesivir Orphan Drug Designation https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-request-to-rescind-remdesivir-orphan-drug-designation 21 comments wallstreetbets
- Promising coronavirus treatment entering Phase 3 Human trials https://www.gilead.com/purpose/advancing-global-health/covid-19 30 comments worldnews